Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 81 - 90 of about 2057

Scientific:
   Lutjanus argentimaculatus (Isu) 

Synonyms:
   Lutianus argentimaculatus 
   Lutjanus argentimaculatus (Mangrove snapper) 
   Lutjanus argentimculatus 
   Sciaena argentimaculata 

Broader Terms:
   Lutianus 
   Lutjanus (common snappers) 
   Perciformes (perch-likes) 
   Sciaena (black drums) 
 
 
Latest Articles on Isu from uBioRSS


External Resources:

Did you mean: Izu or Izuus?



81.  Compliance with orthokeratology care among parents of young children in Taiwan.LinkIT
Chang LC, Sun CC, Liao LL
Contact lens & anterior eye : the journal of the British Contact Lens Association, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

82.  Former Neonatal Intensive Care Unit Fathers' Involvement 4 Years Later: A Qualitative Study.LinkIT
Clarkson G, Hearn G
Journal of pediatric nursing, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

83.  Impact on Mechanical Properties of 10 versus 20 Minute Treatment of Human Pericardium with Glutaraldehyde in OZAKI Procedure.LinkIT
Koechlin L, Isu G, Borisov V, Robles Diaz D, Eckstein FS, Marsano A, Reuthebuch O
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

84.  A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis.LinkIT
Brufsky A, Kim SB, Zvirbule ?, Eniu A, Mebis J, Sohn JH, Wongchenko M, Chohan S, Amin R, Yan Y, McNally V, Miles D, Loi S
Annals of oncology : official journal of the European Society for Medical Oncology, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

85.  Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk.LinkIT
Pastori D, Poli D, Antonucci E, Menichelli D, Violi F, Palareti G, Pignatelli P,
International journal of clinical practiceInt J Clin PractSex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk.e1406410.1111/ijcp.14064Vitamin K antagonists (VKAs) reduce thromboembolism in patients with mechanical prosthetic heart valves (MPHV). It is unclear whether a sex-based difference in MPHV patients regarding valve site, anticoagulation quality, and mortality risk does exist.We analysed 2111 MPHV patients from the nationwide PLECTRUM study promoted by the Italian Federation of Anticoagulation Clinics (FCSA). We analysed the site of MPHV, anticoagulation quality, as assessed by the time in therapeutic range (TiTR), and mortality risk in women and men.The mean age of the patients was 56.8 ± 12.3 years. Women were older with a lower prevalence of ischemic heart disease and smoking habit and a higher prevalence of atrial fibrillation at baseline. Aortic MPHV was more frequent in men (74.7% vs 43.3%, P < .001), whereas mitral (41.1% vs 17.6%, P < .001) and mitro-aortic (15.6% vs 7.7%, P < .001) MPVH in women. The association between female sex and mitral/mitro-aortic site remained at multivariable logistic regression analysis (Odds Ratio 3.623, 95% Confidence Interval [CI] 2.947-4.455, P < .001). Regarding anticoagulation quality, women showed lower mean TiTR (63.0 ± 19.4 vs 57.5 ± 19.2, P < .001), and a higher proportion of TiTR < 60% (54.9% vs 43.3%, P < .001). During a mean follow-up of 123 months (21 665 pt-years), 152 deaths occurred (0.7%/year); 83 in the aortic (0.63%/year) and 69 in the mitral/mitro-aortic (0.81%/year) group. At multivariable Cox proportional hazard regression analysis, female sex was not associated with mortality (HR 0.953, 95%CI 0.678 1.340, P = .783).Female sex is independently associated with mitral/mitro-aortic MPHV. Despite a lower TiTR in women, mortality risk did not differ between the two groups.© 2021 John Wiley & Sons Ltd.PastoriDanieleDhttps://orcid.org/0000-0001-6357-5213I Clinica Medica, Atherothrombosis Centre, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.PoliDanielaDThrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.AntonucciEmiliaEArianna Anticoagulazione Foundation, Bologna, Italy.MenichelliDaniloDhttps://orcid.org/0000-0001-9467-5903I Clinica Medica, Atherothrombosis Centre, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.VioliFrancescoFI Clinica Medica, Atherothrombosis Centre, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.PalaretiGualtieroGArianna Anticoagulazione Foundation, Bologna, Italy.PignatelliPasqualePI Clinica Medica, Atherothrombosis Centre, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.Italian Federation of Anticoagulation Clinics (FCSA)engJournal Article20210211EnglandInt J Clin Pract97123811368-50310AnticoagulantsIMAdultAgedAnticoagulantstherapeutic useAortic ValvesurgeryFemaleHeart Valve Prosthesisadverse effectsHeart Valve Prosthesis ImplantationHeart ValvesHumansItalyMaleMiddle AgedRisk FactorsTestaSophieSPaolettiOrianaOLodigianiCorradoCFerrazziPaolaPQuagliaIlariaICoffettiNadiaNMarottaRosaRBruseganVaruscaVBergamelliOrazioOLombardoAlzanoAFacchinettiRobertoRSerricchioGiuseppinaGSarpauSilviaSBreviFrancescaFComoLarianaLFalcoPietroPSilverioGuarinoGMangioneCatelloCBellomoGiacomoGMasottiniSerenaSCosenzaAlessandraARuoccoLuciaLChiarugiPaoloPCasiniMonicaMCafollaArturoAFerrettiAntoniettaAMicucciGiorgiaGRupoliSerenaSCanafogliaLuciaLPedicoPaoloPGalassoRitaRRotunnoRosaRDimiccoli BarlettaRaffaeleRInsanaAntonioAValesellaPaoloPSantoroAngeloAMarongiuFrancescoFBarcellonaDorisDPengoVittorioVDenasGentianGPaparoCarmeloCBucheriniEugenioETaniFlaviaFCarioliEnricoEVicarioTommasaTSaliolaMirellaMMascioccoLucillaLSaracinoPasqualePBenvenutoAngeloATurriniAnnaACiaffoneStefanoSTomaAndreaABarberaPietroPGreselePaoloPFierroTizianaTPasquinoStefanoSRosaLucia LaLMoralesRinoRRonchiFrancescoFIsuGiuseppeGLeredeTeresaTBarcellaLucaLCrisantemoRosannaRSurianoLucianoLLorussoLucianoLSarloMarioMCarratoPasqualePOricchioCarmineCGrandoneElviraEColaizzoDonatellaDMolinattiMaurizioM20210117202012192021012920212460202142760202123839ppublish3353355510.1111/ijcp.14064REFERENCES, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>86.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Utilizing technology to enhance laboratory-client interaction while encouraging best behavior.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Woodard K, Kraft J, Adhikari S, Patanroi D, Crim B, Berghefer R, Main R<br><font color=gray><i>Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>87.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Student Perspectives of Integrated Clinical Practicum Experiences in Physical Therapy Education: A Pilot Study.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Gerber LD, Gee BM, Vail KB, Lloyd K, Jackman T, Ralphs J<br><font color=gray><i>Journal of allied health, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>88.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>You CW, Hong SB, Kim S, Shin HJ, Kim JS, Han JW, Kim SJ, Kim DY, Lee M, Levy H<br><font color=gray><i>Journal of thrombosis and haemostasis : JTHJ Thromb HaemostSafety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients.967-97510.1111/jth.15259Dalcinonacog alfa (DalcA), a next-generation, recombinant human factor IX (FIX) variant, was developed using a rational design approach for increased procoagulant activity and longer duration of action to be administered subcutaneously (SC) for prophylaxis of hemophilia B bleeding episodes.To investigate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of DalcA.This multicenter, phase 1/2a study (NCT03186677) was conducted in 11 males aged 12 to 65 years with severe hemophilia B. In cohort 1, subjects received intravenous (IV) 75 IU/kg BeneFIX and DalcA. Cohorts 2 and 3 had DalcA IV 75 IU/kg and SC 75 IU/kg or 150 IU/kg. Cohort 4 was omitted. Cohort 5 received daily SC 150 IU/kg DalcA for 6 days and cohort 6 received IV 75 IU/kg and daily SC 150 IU/kg DalcA for 9 days. Blood sampling was performed for chemistry, hematology, PK, PD, and anti-drug antibody measurement. Subjects were monitored for safety endpoints for 30 days postdosing.DalcA demonstrated a 24-fold greater potency over BeneFIX and longer mean residence time (33.8 h). SC bioavailability 8.2% to 20.3%, beta half-life 53.9 to 106.9 h and Tmax 24 to 48 h. A median 15.7% FIX activity level (interquartile range, 14.9%-16.6%) was reached after 6 daily doses. Neutralizing antibodies to ISU304, but not wild-type FIX, occurred in two cousins.The data demonstrated that DalcA achieved protective FIX activity levels between 11% and 18%, corresponding to a reduced chance of spontaneous bleeds. Based on the results, a phase 2b trial to assess the safety and efficacy of 28 daily SC doses of DalcA was performed.© 2021 International Society on Thrombosis and Haemostasis.YouChur WooCWEulji University Hospital Seo-gu, Daejeon, Korea.HongSeung-BeomSBISU Abxis, Sungnam-si Gyeonggi-do, Korea.KimSuyeongSISU Abxis, Sungnam-si Gyeonggi-do, Korea.ShinHo-JinHJPusan National University Hospital, Busan, Korea.KimJin SeokJS0000-0001-8986-8436Yonsei University College of Medicine, Severance Hospital, Korea.HanJung WooJWYonsei University College of Medicine, Severance Hospital, Korea.KimSoo-JeongSJYonsei University College of Medicine, Severance Hospital, Korea.KimDo YoungDYPusan National University Hospital, Busan, Korea.LeeMartinMFielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.LevyHowardHCatalyst Biosciences, South San Francisco, California, USA.engClinical Trial, Phase IClinical Trial, Phase IIJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov't20210324EnglandJ Thromb Haemost1011705081538-78360Recombinant Proteins9001-28-9Factor IXIMAdolescentAdultAgedBlood Coagulation TestsChildFactor IXHalf-LifeHemophilia AHemophilia Bdiagnosisdrug therapyHumansMaleMiddle AgedRecombinant ProteinsYoung Adultblood coagulationfactor IXhemophilia Binjectionsrecombinant proteinssubcutaneous202012152020100120201223202125602021515602021242022ppublish3354048510.1111/jth.15259REFERENCES, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>89.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Developing a theory to guide nurse practitioners to accomplish [a] training programme: A grounded theory study.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Ting YC, Chiang CY, Lu CY, Sun FK<br><font color=gray><i>Nurse education today, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>90.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Introduction to the JBCB Special Issue on Selected Papers from BICOB-2020.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Eulenstein O, Ding Q, Al-Mubaid H<br><font color=gray><i>Journal of bioinformatics and computational biology, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br><br><br><table cellspacing=0 cellpadding=0 align=center><tr valign=bottom><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=8><img src=p.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=1><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=2><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=3><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=4><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=5><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=6><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=7><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=8><img src=o_yellow.png border=0></a></td><td align=center><img src=o_red.png border=0></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=10><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=11><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=12><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=13><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=14><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=15><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=16><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=17><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=18><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=10><img src=rtal.png border=0></a></td></tr><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=8>«</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=1>1</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=2>2</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=3>3</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=4>4</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=5>5</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=6>6</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=7>7</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=8>8</a></td><td align=center>9</td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=10>10</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=11>11</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=12>12</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=13>13</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=14>14</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=15>15</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=16>16</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=17>17</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=18>18</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Isu&category=l&client=pubmed&startPage=10>»</a></td></tr></table></table></tr></table></td><script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-634822-1"; urchinTracker(); </script> </BODY> </HTML>